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Quantification of basal digital blood flow 
and after cold stimulus by laser doppler 
imaging in patients with systemic sclerosis
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INtrODuCtION
Systemic sclerosis (SSc) is an autoimmune disease of unknown 
etiology characterized, clinically, by vascular involvement and 
fibrotic changes of the skin and internal organs.1 The early 
detection of peripheral vascular changes, characterized by 
structural and functional abnormalities in small blood vessels 
and microcirculation, is possible in the majority of the cases.
Raynaud’s phenomenon (RyP), seen as the first manifestation 
in 70% of the patients and in up to 95% of the cases during 
the evolution of the disease, is the most evident and earlier 
aBStraCt
Objectives: The objective of this study was to investigate the dynamic behavior of the blood flow of the microvascular 
circulation of the fingertips before and after two cold stimuli (CS), using Laser Doppler Imaging with different intensities 
in patients with systemic sclerosis (SSc) and in healthy individuals. Patients and Methods: Fourteen SSc patients (51.2 
± 5.5 years) with Raynaud’s phenomenon and 12 healthy controls (44.8 ± 9.0 years) were included in this study. Two 
CS protocols (submersion of the hands in water at 10 °C or 15 °C for 1 minute) were performed on the same day. Mean 
fingertip blood flow (FBF) of four digits of the left hand was measured using LDI (Moor LDI-VR, Moor Instruments) 
at baseline and at 1, 4, 10, 25, and 40 minutes after CS. Results: Baseline blood flow was significantly lower in both 
CS protocols in SSc patients when compared to controls (312.9 ± 102.7 vs 465.4 ± 135.4 PU, P = 0.006 at 15 °C; 305.2 
± 121.0 vs 437.9 ± 119.8 PU; P = 0.01 at 10 °C). In the control group, a significant decrease in FBF after CS, when 
compared to baseline, was observed 1 minute (P = 0.001) after CS at 15 °C and at 1 (P = 0.005) and 25 minutes (P = 
0.001) after CS at 10 °C. In SSc patients, a significant decrease in FBF was observed in both CS protocols at 1, 4, and 
10 minutes (P < 0.000; P = 0.002; P = 0.014, after CS at 15 °C; P < 0.000; P = 0.004; P = 0.001, after CS at 10 °C). 
Conclusions: Laser Doppler Imaging showed lower baseline fingertip perfusion and further reduction after CS in SSc 
patients compared to controls. Quantification of fingertip blood flow by LDI may be useful in the longitudinal monitoring 
of the disease status and therapeutic interventions in SSc.
Keywords: systemic sclerosis, Raynaud’s phenomenon, microcirculation, Laser Doppler Imaging.
clinical manifestation of vascular involvement.2 Raynaud’s 
phenomenon is defined as an abnormal vasoconstriction 
in response to cold, causing recurring episodes of spasm 
of digital arteries, arterioles, and cutaneous arteriovenous 
shunts. It is characterized by typical color changes of the 
extremities, especially hands and feet, that classically have 
three phases: pallor, cyanosis, and rubor. Structural changes 
of the microcirculation, endothelial damage and dysfunction, 
and platelet activation, which usually make vasospastic events 
more severe, are present in RyP secondary to SSc, or diseases 
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of the same spectrum.3 Marked reduction in blood flow, and 
even complete occlusion of the vessel, can be seen. All those 
changes can lead to chronic tissue hypoxia and irreversible 
tissue damage with recurring ulcers, scars, and, in more severe 
cases, gangrene and amputation of the extremities.4
Accurate methods for the evaluation and quantification of 
the changes present in the microcirculation in patients with 
RyP and SSc, may it be to study the pathophysiology of the 
disease or to differentiate patients with secondary RyP from 
those with primary RyP, have to be developed.5 Besides, with 
the advent of new treatment modalities for SSc and associated 
RyP, objective and reproducible methods to evaluate the 
response to therapy are increasingly more necessary. Those 
methods could be associated, or not, with acute ischemia 
provocation tests - immersion of the extremities in cold water 
or insufflation of pneumatic devices.6,7 Currently, a method 
considered the gold-standard to evaluate the blood flow in 
the microcirculation in patients with primary RyP or SSc 
does not exist. Laser Doppler flowmettrics, a non-invasive 
method that provides quantitative evaluation of the blood 
flow in the microcirculation, is based on the Doppler effect of 
beams reflected by moving blood cells.8 Conventional Laser 
Doppler evaluates only a small circumscribed point of the skin 
each moment, and great signal variability among different 
areas represents an important limitation, making it a poorly 
reproducible method, limiting its use in therapeutic assays.9,10 
Laser Doppler Imaging (LDI) is based on a relatively recent 
technique that allows direct measurements of the blood flow of 
the cutaneous microcirculation over a wider area and not only 
in a single point. It also has the advantage of not requiring direct 
contact with the skin surface, eliminating changes secondary 
to pressure, or artifacts caused by movements.11,12 Due to the 
precision and reproducibility, LDI is considered a promising 
method for the dynamic evaluation of the blood flow in RyP 
and in patients with SSc.13
In the present study, the response of the microcirculation 
to two cold stimuli of different intensities in healthy controls 
and in patients with SSc was evaluated. Our intention was to 
evaluate the dynamic behavior of the digital blood flow in 
healthy individuals and SSc patients.
PatIENtS aND mEtHODS
A transversal study with patients with the diagnosis of SSc, 
according to the ACR classification,14 who also had RyP and 
periungueal capillaroscopy with SD (scleroderma pattern) 
microangiopathy,15 from the Systemic Sclerosis Outpatient 
Clinic of HSP-UNIFESP, was undertaken. Healthy controls, 
paired by gender and age, were selected among the employees 
of Hospital São Paulo. Exclusion criteria were: smoking, 
diabetes, severe hypertension (diastolic blood pressure > 
105 mmHg), or patients with clinically significant central 
vasculopathy and/or peripheral venous vasculopathy. Any 
vasodilators used by patients were discontinued three days 
before the tests. All patients should be older than 18 years and 
they had to sign an informed consent approved by the Ethics 
Commission of UNIFESP under protocol #1,298/06.
After an adaptation period (rest for one hour in a room the 
with temperature of 24 ± 1° C, with their hands most of the time 
in the axillary region to keep them warm), patients and controls 
underwent two consecutive protocols of cold stimuli on the 
same day with a minimal inter-test interval of 60 minutes. The 
specific conditions of both protocols were as follows: 
Part I: Assessment of vasoreactivity of 
the cutaneous microcirculation in the 
presence of a cold stimulus at 15° C
A – Assessment of the baseline blood flow of the cutaneous 
microcirculation by Laser Doppler Imaging. The left hand of 
all individuals was placed on a flat surface (at the level of the 
heart), and the blood flow on the dorsal region of the distal 
phalange of four fingers (except the thumb) of the left hand 
was evaluated in basal conditions by Laser Doppler Imaging 
(Moor LDI, Moor Instruments, Axminster, UK). This device 
uses a low intensity helium-neon red laser beam with 633 nm 
with penetration in the skin surface of approximately 1 mm. 
The light beam is directed to the selected area of the skin by a 
mirror located at 40 cm from the skin surface. All images were 
captured at a rate of 4 pixels/millisecond, with acquisition time 
of 3 minutes and 15 seconds for each image. The mean blood 
flow of the selected area was determined with the help of the 
MoorLDI V5.2 software and expressed in arbitrary perfusion 
units (PU) in relation to an internal standard calibration of the 
device. The mean blood flow of the four fingertips (FBF) was 
considered for analysis.
B – Cold stimulus (CS). Cold stimulus was applied by 
immersion of both hands in water at 15° C for 60 seconds 
(UNITEMP 116, Fanem, Brazil).
C – Monitoring the blood flow in the cutaneous 
microcirculation by Laser Doppler Imaging after the Cs. The 
FBF of the dorsum of the four fingers (except the thumb) of 
the left hand was measured continuously, as described, up to 
25 minutes after the CS. The blood flow measured at 1, 4, 10, 
and 25 minutes after CS was considered for analysis.
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Table 1
Demographic data of patients with systemic sclerosis (SSc) and healthy controls
SSc patients (n = 14) Healthy controls (n = 12) P
age (years) 51.2 ± 5.5 44.8 ± 9.1 NS
Gender 13F/1m 9F/3m NS
Clinical type 5 Diffuse/9 Limited – –
Duration of ryP (years) 9.4 ± 6.1 – –
Duration of the disease (years) 9.4 ± 5.8 – –
Number of patients with active ulcers (%) 6 (42.8) – –
Positive aNF (n) 13 – –
Positive anti-Scl 70 (n) 2 – –
Positive anti-centromere (n) 5 – –
NS: non-significant; RyP: Raynaud’s phenomenon; ANF: anti-nuclear antibody.
Part II: Assessment of the vasoreactivity 
of the cutaneous microcirculation in the 
presence of a cold stimulus of 10° C
The protocol described in Part I was repeated, observing a 
minimal interval of 60 minutes between both CS. The main 
difference relied on the CS, which consisted on immersion in 
water at 10° C for 60 seconds. The blood flow in the cutaneous 
microcirculation was monitored up to 40 minutes after the 
CS and measured at 1, 4, 10, 25, and 40 minutes after the CS, 
represented another difference in relation to part I.
Statistical analysis
To better detect the dynamic changes in FBF secondary to 
the CS, the percentage variation in post-CS FBF in relation to 
pre-CS FBF, called ∆FBF, was used, in which:
∆FBF =
 post-CS FBF – pre-CS FBF x 100  
  Pre-CS FBF
Results were expressed as mean ± standard deviation. The 
Student t test was used for intergroup analyses, while ANOVA 
for repeated measurements was used to compare the groups along 
time. A level of significance of 0.05 was adopted in all the analyses.
rESuLtS
Fourteen SSc patients, with mean age of 51.2 years (ranging 
from 41 to 60 years), and 12 healthy controls, mean age of 44.8 
years (ranging from 33 to 54 years), were included in the study. 
Five patients (35.7%) had limited cutaneous disease and nine 
(64.3%) had diffuse cutaneous disease (Table 1). The duration 
of the disease in patients with the limited cutaneous type was 
10.5 ± 4.2 years and the onset of RyP was 12.2 ± 5.1 years ago. 
In patients with the diffuse cutaneous type, the duration of the 
disease was 8.3 ± 5.6 years and the onset of RyP was 7.3 ± 6.4 
years ago. Ten patients were being treated with vasodilators 
(calcium channel blockers, captopril, and losartan).
Basal FBF was significantly lower in SSc patients than in 
the controls in both CS protocols (312.9 ± 102.7 versus 465.4 ± 
135.4 PU, P = 0.006, before CS at 15° C; 305.2 ± 121.0 versus 
437.9 ± 119.8 PU, P = 0.01, before CS at 10° C) (Figure 1). 
Baseline FBF in healthy controls did not differ between the 
first and second CS (P = 0.341) or in SSc patients (P = 0.679), 
confirming the reproducibility of the method. The mean blood 
flow in the fingertips was significantly lower in SSc patients 
when compared to the  control group at all times after CS at 
15° C (P = 0.005, 1 minute after Cs; P = 0.009, 4 minutes after 
CS; P = 0.001, 10 minutes after CS; and P = 0.016, 25 minutes 
after CS), and at 1, 4, and 10 minutes after CS at 10° C ( P < 
0.001; P = 0.008; and P = 0.002, respectively) (Table 2).
An abrupt fall in FBF was observed 1 minute after both CS 
in SSc patients and in the control group, followed by a gradual 
recovery of the blood flow, which was delayed in SSc patients 
(Figure 2). In healthy controls, a significant reduction in FBF 
was observed after CS at 15° C, when compared to baseline 
levels, 1 minute after CS (P = 0.001). This group showed 
fast recovery of FBF and statistically significant differences 
among basal FBF and FBF 4, 10, and 25 minutes after CS at 
15° C (P = 0.055; P = 0.55; and P = 1.00, respectively) were 
not observed. At 10° C, significant differences were observed 
in post-CS FBF at 1 and 25 min when compared to baseline 
levels (P = 0.005; P = 0.001, respectively) in the control group. 
In SSc patients, a significant reduction was observed in FBF 
1, 4, and 10 minutes after CS at 15° C (P < 0.000; P = 0.002; 
and P = 0.014, respectively) and 10° C (P < 0.000; P = 0.004; 
P = 0.001, respectively). A recovery in FBF was observed only 
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Figure 1
Baseline blood flow in a healthy control (A) and in one patient with 
systemic sclerosis (B) on Laser Doppler Imaging. 
B
a
Table 2
Mean blood flow, in the fingertips of four fingers, in perfusion units (PU) and percentage variation, after cold 
stimulus at 15° C and 10 °C (∆EF - FBF) in patients with systemic sclerosis (SSc) and healthy controls
Cold stimulus a 15ºC
Baseline 1 min 4 min 10 min 25 min
Controls 465.43 ± 135.38 273.27 ± 183.22 345.33 ± 196.84 424.57 ± 151.45 419.77 ± 147.08
SSc 322.91 ± 102.72 115.89 ± 55.07 172.13 ± 108.88 223.56 ± 106.79 284.92 ± 117.83
∆EF-FPD controls -41.2 ± 30.18% -25.7 ± 20.2% -8.7 ± 2.26% -9.8 ± 6.45%
∆EF-FBF SSc -64.1 ± 48.7% -46.6 ± 7.2% -30.7 ± 18.32% -11.7 ± 5.0%
P (FPD controls versus SSc) 0.006 0.005 0.009 0.001 0.016
Cold stimulus a 10ºC
Baseline 1 min 4 min 10 min 25 min 40 min
Controls 437.97 ± 119.79 283.43 ± 138.72 299.10 ± 169.63 381.20 ± 153.35 275.48 ± 107.55 312.75 ± 161.59
SSc 305.16 ± 121.00 83.76 ± 43.83 133.97 ± 118.39 199.3 ± 105.79 227.44 ± 126.82 255.50 ± 124.46
∆EF-FBF controls -35.2 ± 12.84% -31.7 ± 12.4% -12.9 ± 10.40% -37.1 ± 25.10% -28.5 ± 17.38%
∆EF-FBF SSc -72.5 ± 62.87% -56.0 ± 21.2% -34.6 ± 22.93% -25.4 ± 6.39% -16.2 ± 5.02%
P (FBF controls versus SSc) 0.01 0.000 0.008 0.002 0.312 0.247
25 minutes after CS (P = 0.146 at 15° C; P = 0.25 at 10° C) 
(Figure 2). The magnitude of the reduction in FBF (∆CS-FBF) 
was greater in SSc patients than in healthy controls 1 minute 
after CS at 10° C (-72.5 ± 63% versus -35.3 ± 15%) (Table 2).
DISCuSSION
In the present study, we undertook a novel evaluation of the 
dynamic behavior of the blood flow in the microcirculation 
of the digits, before and after two cold stimuli of different 
intensities, by comparing the LDI of patients with RyP 
secondary to SSc and healthy individuals. The FBF of patients 
with systemic sclerosis was considerably lower than in healthy 
controls. As expected, a significant reduction in FBF was 
observed in both groups after CS, both at 15° C and 10° C, 
and this reduction was more marked in SSc patients. Healthy 
controls showed fast recovery in FBF, especially after CS at 
15° C (observed 4 minutes after CS); the same was not true for 
SSc patients, who had delayed recovery of FBF. The recovery 
curve after CS at 15° C was capable to better characterize 
both groups.
The findings of lower baseline FBF levels in SSc patients 
confirm prior studies that reported conspicuous morphological 
changes, devascularization, and reduction in blood flow in the 
small vessels and microcirculation of those individuals.16,17 
The greater reduction in FBF observed in the majority of SSc 
patients might be due to changes in blood flow dynamics that 
are worsened by unfavorable conditions secondary to structural 
changes in the microcirculation observed in those individuals. 
The vasoreactivity of the cutaneous microcirculation is, 
usually, a protective response to heat loss. After a cold stimulus, 
Corrêa et al.
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Figure 2
Mean blood flow, in perfusion units (PU), in the fingertips of patients 
with systemic sclerosis (SSc) and healthy controls before and after cold 
stimulus at15 °C (A) and 10 °C (B).
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SSc patients show a knowingly exacerbated response to acute 
ischemia, with sudden increase in vascular tonus, marked 
reduction of the blood flow, and even possible closure of 
digital arterioles.18,19
The consistent and objective reproduction, in clinical 
practice, of the vasospastic events in patients with primary or 
secondary RyP is difficult. Several methods for the objective 
measurement of the severity of cold vasoreactivity in each 
patient with RyP, such as thermography, digital systolic blood 
pressure, fingertip lacticemy, plethysmography, conventional 
Laser Doppler, and LDI, are used.5,12,19-23 Thermography 
evaluates, indirectly, the temperature of the skin of a specific 
area. Digital systolic blood pressure is useful to evaluate the 
blood flow of the digital artery; however, it does not evaluate 
the microcirculation. Plethysmography evaluates changes in 
blood volume in specific segments and it seems to be a poorly 
reproducible method.5 On the other hand, LDI allows the 
evaluation of larger areas of the cutaneous microcirculation, 
and its results are more reproducible and representative when 
compared to conventional Laser Doppler. Clark et al.10 used 
LDI to evaluate the blood flow on the back of the hands in 
patients with primary RyP and diffuse cutaneous SSc, limited to 
the room temperature of 23° C and 30° C. The authors observed 
significant differences in blood flow among the four study 
groups, especially when evaluating  the maximal difference 
in blood flow among the different fingers of the same hand at 
a room temperature of 23° C. Note that the most expressive 
differences were observed in patients with limited cutaneous 
SSc and smaller differences in healthy controls.
Laser Doppler Imaging was also used to assess the 
therapeutic response to topical glyceryl trinitrate in patients 
with primary RyP and in SSc patients24. An increase in 
digital blood flow was observed in all patients after applying 
glyceryl trinitrate when compared to placebo. More recently, 
when evaluating the long-term treatment with intravenous 
N-acetylcysteine in RyP secondary to SSc, Salsano et al.25 
observed a significant increase in global perfusion of the 
hands on LDI after treatment. Those studies indicate that Laser 
Doppler Imaging is a powerful tool in the quantification of the 
blood flow in the microcirculation and objective monitoring 
of the therapeutic response in patients with RyP and SSc. 
However, until now, very few studies have evaluated the 
vasoreactivity of cutaneous microcirculation in response to 
a cold stimulus in patients with RyP and/or SSc using this 
method.12,26 Picart et al.26 evaluated digital perfusion before 
and after cold stimuli (cold plate at 5° C for 8 minutes) with 
LDI in eight patients with SSc, ten with primary RyP, and 
seven healthy controls. Similar to the results of the present 
study, SSc patients showed lower baseline blood flow and 
marked decrease after the cold stimulus when compared to 
healthy controls.
Different protocols of cold stimuli, such as immersion of 
both hands or one hand in water at different temperatures (ice 
until 20° C) and total body cooling are used for the objective 
evaluation of vasoreactivity in patients with RyP.27-30 In our 
study, we performed two protocols aiming at standardizing 
CS test with LDI and quantify, objectively, changes in blood 
flow in the microcirculation related to the pathophysiology of 
RyP. To this end, we attempted to evaluate which CS would 
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be better to distinguish healthy individuals from patients with 
RyP secondary to SSc. Cold stimulus at 15° C for 1 minute 
was used by O’Reilly et al.,30 and it was considered adequate 
to evaluate blood flow recovery curves in the presence of a CS. 
Our group has used the cold stimulus at 10° C, in association 
with lacticemy test of the fingertips, in several studies, showing 
that it is capable of differentiating patients with secondary RyP, 
primary RyP, and healthy controls.21-23 However, CS at 10° C is 
more uncomfortable and potentially more damaging for patients 
with RyP. The present study demonstrated that very intense 
or prolonged CS is not necessary to produce vasospasm or 
distinguish patients with secondary RyP from healthy individuals 
by LDI. Besides, based on the results of the present study, CS 
at 10° C also seemed to cause severe vasoconstriction, even 
in healthy individuals, therefore hindering the discrimination 
between patients and healthy controls.
One should not forget that measurements of peripheral 
blood flow can be influenced be a series of factors, such as low 
environmental temperature, length of acclimatization, smoking, 
hormonal changes, use of vasodilators or vasoconstrictors, and 
stress.31,32 In our study, we tried to minimize the influence 
of extrinsic factors by applying a homogenous protocol, 
consisting on individual adjustment in a calm environment 
with controlled temperature, exclusion of smokers, and 
discontinuation of vasodilators three days before the tests, to 
all participants. 
In conclusion, the present study showed significant lower 
levels of basal FBF in SSc patients when compared to healthy 
controls. A significant reduction in FBF was observed in 
both groups after CS, especially 1 minute after CS in both 
protocols. Cold stimulus at 15° C differentiated better both 
groups. Quantification of FBF associated with a CS could, 
therefore, be useful in the evaluation for therapeutic assays and 
longitudinal follow-up of patients with RyP secondary to SSc. 
Prospective studies with a greater number of SSc patients and 
patients with primary RyP could better define the role of LDI 
in the diagnosis and monitoring of those patients.
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